Vertebroplasty and Kyphoplasty Needles Market

Vertebroplasty and Kyphoplasty Needles Market Industry Outlook (2022-2032)

Valued at US$ 829 Million in 2021, the vertebroplasty and kyphoplasty needles market is expected to take a turn for the better to reach US$ 874 Million by 2022, reflecting a Y-o-Y growth rate of 5.4%. During the 2022-2032 forecast period, sales of vertebroplasty and kyphoplasty needles are expected to flourish at a 4.8% CAGR, reaching US$ 1.4 Billion.

The market is expected to show a remarkable growth in the forecast period owing to the rise in the incidence of spinal injuries as a result of car accidents and sports injuries. Moreover, the rapidly increasing geriatric population suffering from osteoporosis is boosting the market for vertebroplasty and kyphoplasty needles.

Report Attributes	Details
Anticipated Base Year Value (2021)	US$ 829 Million
Projected Current Market Value (2022)	US$ 874 Million
Expected Forecast Value (2032)	US$ 1.4 Billion
Growth Rate (2022-2032)	4.8% CAGR
Expected Market Value of the U.S (2032)	US$ 499 Million
Anticipated Growth Rate of China (2022-2032)	4.3% CAGR
Key Companies Profiled	Stryker Corporation Medtronic Plc. IZI Medical Products Globus Medical Inc. Biopsybell Laurane Medical Teknimed Merit Medical Systems Inc. Zavation

What are the Key Factors Propelling the Vertebroplasty and Kyphoplasty Needles Market Growth?

Rising Incidence of Minimally invasive Surgical Procedures for Various Chronic Ailments

Because of the surge in popularity of minimally invasive surgical procedures and technological breakthroughs in the healthcare sector, the vertebroplasty and kyphoplasty needles market is expected to grow during the forecast period of 2022-2032.

Bone cement is injected into the vertebra to support the specific broken bone during vertebroplasty. Kyphoplasty is a modified version of vertebroplasty in which a balloon tamp is inflated in the vertebral area to compress and form a cavity in the cancellers’ bone.

Rising cases of vertebral fractures in the young population as a result of high-velocity injuries while exercising or performing other activities are positively impacting the vertebroplasty and kyphoplasty needles market.

What are the Major Trends in the Global Vertebroplasty and Kyphoplasty Needles Market?

The vertebroplasty and kyphoplasty needles market is benefiting greatly from advances in image-guided surgical procedures. Innovations and new technology development based on research activities conducted by manufacturers in the vertebroplasty and kyphoplasty needles market are proving to be growth generators for the vertebroplasty and kyphoplasty needles market.

Frequent mergers and acquisitions may have a positive impact on the vertebroplasty and kyphoplasty needles market growth rate.

What Challenges are in Store for Vertebroplasty and Kyphoplasty Needles Sales?

The main factor impeding the growth of the vertebroplasty and kyphoplasty needles market, such as high surgical costs as well as the presence of alternative devices. Moreover, the overall complication rate of vertebroplasty and kyphoplasty is low, ranging from 2% when treating osteoporotic compression fractures to 10% when treating malignant tumors [30, 39, 52, and 53].

Extravasation of the cement into the epidural space causes more serious complications with vertebroplasty and kyphoplasty. Although vertebroplasty is widely regarded as a relatively safe procedure for relieving pain caused by a vertebral compression fracture, it is still surgery and carries some risks. Henceforth, all these factors are anticipated to hamper the market growth during the forecast period.

Comparative View of Adjacent Vertebroplasty and Kyphoplasty Needles Market

Vertebroplasty and Kyphoplasty Needles Market :

Attributes	Vertebroplasty and Kyphoplasty Needles Market
CAGR (2022-2032)	4.8%
Market Value (2032)	US$ 1.4 Billion
Growth Factor	Increasing prevalence of back injuries is anticipated to propel the market growth significantly.
Opportunity	Technological advancements in health care sector are expected to offer remunerative opportunities for market growth.

Chronic Lower Back Pain Market :

Attributes	Chronic Lower Back Pain Market
CAGR (2022-2032)	4.7%
Market Value (2032)	US$ 11 Billion
Growth Factor	During the forecast period, the major growth drivers for the Chronic Lower Back Pain Market are an increase in the emergence of nerve cases and an increase in the geriatric population.
Opportunity	Inactive lifestyles, rising healthcare awareness in developed and developing countries, and rising disposable income of consumers are expected to support market growth in the assessment period.

Spinal Devices Market :

Attributes	Spinal Devices Market
CAGR (2022-2032)	3.5%
Market Value (2032)	US$ 20 Billion
Growth Factor	The global market for spinal devices is expected to be driven by technological advancements, an increase in the number of spinal surgeries and population ageing.
Opportunity	Growing use of spinal devices in geriatric as well as arthritis patients are expected to offer positive growth prospects for the global spinal device market during the forecast period.

Country-wise Analysis

What is the Growth Outlook for the U.S Market on Vertebroplasty and Kyphoplasty Needles?

According to Fact.MR’s analysis, the global vertebroplasty and kyphoplasty needles expected to be dominated by the U.S during the forecast period. The evaluation states that the U.S market is predicted to secure a market value of US$ 499 Million while growing at a CAGR of 4.6% during the forecast period from 2022 to 2032.

The country is forecast to maintain its dominant growth trajectory throughout the forecast period, owing to rising adoption of technologically advanced products and the high prevalence of orthopedic disorders. In 2019, North America dominated the market, accounting for more than 35.6% of global revenue. This is due to an increase in the prevalence of osteoporosis in this region, as well as an elevated preference for minimally invasive surgery to treat VCFs.

How do Vertebroplasty and Kyphoplasty Needles Sales Prospects appear across China?

As per the analysis, the Asia Pacific vertebroplasty and kyphoplasty needles market is expected to expand at a relatively high rate during the forecast period, owing to an increased focus on the development of health care infrastructure by both public and private hospitals, as well as an increase in demand for affordable care from a significant patient population.

Out of all countries in Asia Pacific, China is expected to emerge as the strongest market, accelerating at a 4.3% value CAGR from 2022 to 2032. Fact.MR further estimates that the country will likely yield an absolute dollar growth worth US$ 35 Million until 2032, being valued at US$ 102 Million. As of 2022, sales of vertebroplasty and kyphoplasty needles in China are expected to be valued at US$ 67 Million.

Across China, the emphasis on conservative treatment to prevent onset of possible side effects for a variety of diseases has always acquired precedence. At present, clinical trials have concluded that external treatment through Traditional Chinese Medicine, such as acupuncture and acupoint application are highly effective in treating thoracolumbar compression fractures. Hence, demand for vertebroplasty and kyphoplasty needles is rising.

Country	Estimated CAGR
U.S	4.6%
U.K	3.8%
China	4.3%
Japan	3.5%
South Korea	2.4%

Category-wise Insights

By End-Use, which Category is likely to lead Market Growth?

Hospitals to Generate Maximum Demand for Vertebroplasty and Kyphoplasty Needles

Based on end use, hospitals are projected to generate maximum vertebroplasty and kyphoplasty needles demand. As per the analysis, the segment is anticipated to expand at a CAGR of 4.3% during the forecast period from 2022 to 2032.

It is estimated that vertebral compression fractures account for approximately 70,000 hospitalizations each year, especially across countries such as the U.S, thus promoting the growth of the market for vertebroplasty and kyphoplasty needles.

By Procedure, which Category of Vertebroplasty and Kyphoplasty Needles will dominate?

Kyphoplasty Procedures to account for Bulk of all Needles Sales through 2032

According to Fact.MR’s projections, kyphoplasty procedure needles are expected to generate maximum revenue, anticipated to flourish at a CAGR of 4.4% during the 2022-2032 forecast period. Given the high incidence rate of osteoporosis, which lead to 8.9 Million fractures worldwide, most patients are advised to undergo kyphoplasty surgery.

In many cases, vertebral compression fractures result in a kyphosis of the affected vertebral body. Any increase in kyphosis inevitably shifts the center of gravity ventrally. This changes the weight force distribution of remaining vertebral bodies, increasing the possibility of multiple fractures.

Competitive Landscape

As there are varying demands based on utilization, key market manufacturers have been emphasizing more on research and development activities as well as producing innovative product solutions for specific applications. Leading market players have identified how improved accuracy can have a significant impact in a variety of applications.

Market participants in the vertebroplasty and kyphoplasty markets are focused on investing in research and development to develop newer devices with improved technology that would allow surgeons to perform the procedure with ease and improve patient healing. This would help industries improve their market positions. Some of the recent developments in the global vertebroplasty and kyphoplasty needles market are:

• On 26th May 2022, Medtronic Plc. and DaVita Inc. announced their intention to establish a new, independent kidney care-focused medical device company ("NewCo" or "the Company") to improve patient treatment outcomes.
• In September 2020, IZI Medical Products LLC received the CE Mark Approval in Europe for its KivaTM Vertebral Compression Fracture Treatment System. The systems is a unipedicular PEEK implant-based treatment solution for VCFs. The approval has permitted the company enhance its international distribution networks
• Merit Medical Systems announced the launch of ReSolve® Thoracostomy Tray which contains all products required for performing a thoracostomy in April 2022. The ReSolve Thoracostomy Tray is the latest addition to Merit’s Vascular-Peripheral Drainage offering, a portfolio of interventional catheters, stent systems, drainage systems, bottles, procedure trays, sets, and complementary accessories

Key Segments Covered in the Vertebroplasty and Kyphoplasty Needles Industry Report

• by Procedure :

  • Needles for Kyphoplasty Procedures
  • Needles for Vertebroplasty Procedures
    • Directional
    • Straight

• by End User :

  • Hospitals
  • Ambulatory Surgical Centers

• by Region :

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa